DOK2

DOK2

Target · Adaptor protein

DOK2 Docking protein 2 · p56dok-2

DOK2 (docking protein 2, also known as p56dok-2 or Dok-2) is an enzymatically inert adaptor protein of the DOK family. It provides a docking platform for the assembly of multimolecular signalling complexes and is linked to Bcr-Abl and cytokine signalling. Browse Assay Genie's current range of DOK2 research reagents below, or read on for the biology behind the target.

Adaptor, enzymatically inertDocking protein familyCML-associated substrate
412 aa
Protein length
~45 kDa
Molecular weight
8p21.3
Gene locus
DOK family
Protein family
Target information

What is DOK2 (docking protein 2)?

DOK2 belongs to the DOK family of adaptor or scaffolding proteins, which have no enzymatic activity of their own. Instead, they provide a docking platform for the assembly of multimolecular signalling complexes. UniProt places DOK2 in the Type A subfamily of the DOK family, and HGNC classifies it in the docking protein family.

Functional annotation describes several roles in signalling. DOK2 may modulate the cellular proliferation induced by IL-4, as well as IL-2 and IL-3. It may also be involved in modulating Bcr-Abl signalling, and it attenuates EGF-stimulated MAP kinase activation. These properties make the DOK2 protein a useful subject for studies of how adaptor proteins shape cytokine and growth factor responses.

The DOK2 gene encodes a protein that is constitutively tyrosine phosphorylated in haematopoietic progenitors isolated from patients with chronic myelogenous leukaemia (CML) in the chronic phase. It may be a critical substrate for p210(bcr/abl), the chimeric protein whose presence is associated with CML. The encoded protein also binds p120 (RasGAP) from CML cells. The protein was formerly named docking protein 2, 56kD, which is the origin of the alias p56dok-2. The mouse ortholog is Dok2, and the gene sits alongside other DOK family members such as DOK1 and DOK3 in the wider docking protein group.

Adaptor protein signalling

DOK2 acts as a docking platform for multimolecular signalling complexes, making it a model for studying non-enzymatic scaffolds.

Chronic myelogenous leukaemia

DOK2 is constitutively tyrosine phosphorylated in CML progenitors and may be a critical substrate for p210(bcr/abl).

Cytokine signalling

DOK2 may modulate cellular proliferation induced by IL-4, IL-2 and IL-3.

MAPK and Ras regulation

DOK2 attenuates EGF-stimulated MAP kinase activation and binds p120 RasGAP in CML cells.

Background

DOK2 frequently asked questions

What does DOK2 do?

DOK2 is an enzymatically inert adaptor that provides a docking platform for assembling multimolecular signalling complexes. It may modulate proliferation induced by IL-4, IL-2 and IL-3, may modulate Bcr-Abl signalling, and attenuates EGF-stimulated MAP kinase activation.

What other names does DOK2 go by?

DOK2 is also called docking protein 2, p56dok-2 and Dok-2. Earlier HGNC names were docking protein 2, 56kD and docking protein 2, 56kDa. UniProt lists the protein as Docking protein 2, and it belongs to the Type A subfamily of the DOK family.

Is DOK2 linked to disease?

DOK2 is constitutively tyrosine phosphorylated in haematopoietic progenitors from chronic-phase CML patients and may be a critical substrate for p210(bcr/abl). It binds p120 RasGAP from CML cells. A mouse ortholog, Dok2, exists; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other members of the DOK docking protein family with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O60496; product specifications from Assay Genie datasheets.

DOK2 Product listing